In contrast, one meta-review found that IL-6 levels, while elevated, were at least one order of magnitude lower in COVID-19 patients than in those with non-COVID-19-related ARDS and sepsis, suggesting a different mechanism of immune dysregulation [63]. The gene discussed is IL6; the disease is COVID-19.